Liam Ratcliffe, Director at ARRAY BIOPHARMA INC (ARRY), sold 1,673,172 shares at $6.10 ($10.2M) on 2013-09-12, disclosed to the SEC on 2013-09-16.
Open-market sale of $10.2M ARRY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.10 | 807,479 | $4.9M | 48.4% |
| 2 | $6.01 | 546,660 | $3.3M | 32.3% |
| 3 | $6.14 | 319,033 | $2.0M | 19.3% |
| Total | $6.08 avg | 1,673,172 | $10.2M | 100% |
| Filing → |
| ARVN | SELL | 2021-11-09 | $30.9M | — | Filing → |
| ARVN | BUY | 2020-12-21 | $10.0M | — | Filing → |
| PASG | BUY | 2020-03-13 | $9.9M | — | Filing → |